Xiao Shi

3PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 11, 2026
Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.

|Jan 14, 2026
Multi-center multi-omics integration predicts individualized prognosis in medullary thyroid carcinoma.

Yan Zhou, Yingrui Wang, Xiao Shi

|Nov 06, 2023
Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System.

Cenkai Shen, Xiao Shi, Duo Wen

Pageof 1

Frequent Collaborators

1 joint publications

Cenkai Shen

1 joint publications

Duo Wen

1 joint publications

Yuqing Zhang

1 joint publications

Yuxin Du